Midi Health positioned as menopause specialist
Midi Health
This is mainly a distribution advantage, not just a clinical one. In employer benefits, the hard part is not convincing an individual woman to book a visit, it is getting through HR, benefits, legal, and health plan teams at a large company, then serving employees wherever they live. Midi already has both pieces, with Fortune 100 employer relationships and 50 state coverage, which lets it move from pilot conversations to live claims based care much faster as menopause benefits become mainstream.
-
Midi sells into employers as a healthcare provider that can often bill through existing insurance, instead of asking companies to add another PMPM point solution. That makes the buyer conversation simpler, because the employer can offer a menopause benefit without standing up a separate reimbursement system for every employee.
-
Nationwide coverage matters because large employers do not want a benefit that only works in a handful of states. Midi announced 50 state employer availability in late 2023, and now markets itself as available across all 50 states with broad insurance acceptance, which fits the needs of distributed Fortune 100 workforces.
-
The closest comparator is Maven, which already sells broad women and family benefits to multinationals and grew its menopause offering to 550 clients in 2024. That shows the category is real, but it also highlights Midi's angle, a more focused menopause product that can win when employers want a specialist rather than a full family benefits platform.
As more employers add menopause support, the market is likely to split between broad family benefits platforms and focused clinical specialists. Midi is well placed to become the specialist default for large U.S. employers, then expand from menopause into adjacent midlife care categories that raise usage, retention, and employer contract value over time.